期刊文献+

葛根素对2型糖尿病大鼠的肾脏保护作用 被引量:7

Protective effect of perarin on rats with type 2 diabetic nephropathy
原文传递
导出
摘要 目的研究葛根素对糖尿病大鼠的肾脏保护作用。方法 SD大鼠分为正常对照组、糖尿病组、糖尿病大鼠葛根素干预组。以高糖高脂饮食及小剂量连脲佐菌素(30mg/kg)制备2型糖尿病大鼠模型。24周后检测Ⅳ型胶原的蛋白表达。结果Ⅳ型胶原的表达在糖尿病组大鼠显著高于正常对照组,治疗组较糖尿病组明显下降。结论在2型糖尿病大鼠中,葛根素可降低Ⅳ型胶原的表达,延缓糖尿病肾病的发生。 Aim To evaluate the protective of effect of puerarin on rats with type 2 diabetic glomerulopathy. Methods SD rats were randomly divided into normal control group ( group A),diabetes group (group B), diabetes group intervented with puerarin (group C). The type 2 diabetic rat model was made by high-sucrose-high-fat diet and a low dose of STZ (30mg/kg) was injected to them. The level of collagen Ⅳ protein were measured by immunhistological staining 24 weeks after experiment. Results In the diabetic rats ,the level of collagen Ⅳ protein was increased significantly than that of the control group. The level of collagen Ⅳ protein expressed in C group was decresed significantly than that of B group . Conchlsion Puerarin may possesses the effect of inhibiting expression of collagen Ⅳ protein and delaying the occurrence of diabetic nephropathy in the rats.
作者 焦秀敏 李栋
出处 《中国热带医学》 CAS 2010年第5期590-590,617,共2页 China Tropical Medicine
关键词 2型糖尿病大鼠 葛根素 Ⅳ型胶原 Puerarin Diabetic nephropathy Collagen Ⅳ
  • 相关文献

参考文献3

二级参考文献25

  • 1潘竞锵,韩超,谭海荣,肖柳英,庆方,关庆丽,陈文慧.葛根芩连汤对抗地塞米松诱导大鼠胰岛素抵抗作用[J].广东药学,2003,13(6):27-29. 被引量:10
  • 2孙敏,孙晶,朱荃.抗氧化中药对蛋白质非酶糖基化反应的影响[J].南京中医药大学学报,2005,21(2):103-105. 被引量:8
  • 3周运鹏.葛根素药理作用和临床应用研究进展[J].中西医结合杂志,1984,4:699-699.
  • 4Stern M P.Diabetes and cardiovascular disease:the “common soil” hypothesis[J].Diabetes,1995,44:369-374.
  • 5Negri M,Sheiban I,Arigliano P L,et al.Interrelation between angiographic severity of coronary artery disease and plasma levels of insulin,C-peptide and plasminogen activator inhibitor-1[J].Am J Cardiol,1993,72:397-401.
  • 6Thogenson A M,Jansson J H,Boman K,et al.High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial in farction in both men and women:evidence for the fibrinolytic system as an independent primary risk factor[J].Circulation,1998,98:2241-2247.
  • 7Ahmed N.Advanced glycation endproducts-role in pathology of diabetic complications.Diabetes Res Clin Pract 2005,67(1):3-21
  • 8Chang KC,Paek KS,Kim HJ,et al.Substrate-induced up-regulation of aldose reductase by methylglyoxal,a reactive oxoaldehyde elevated in diabetes.Mol Pharmacol 2002,61(5):1184-91
  • 9Song X,Bao M,Li D,et al.Advanced glycation in D-galactose induced mouse aging model.Mech Ageing Dev 1999,108(3):239-51
  • 10Mene P,Festuccia F,Pugliese F.Clinical potential of advanced glycation endproduct inhibitors in diabetes mellitus.Am J Cardiovasc Drugs 2003,3 (5):315-20

共引文献39

同被引文献87

引证文献7

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部